Gb Sciences: PhAROS drug discovery platform
Gb Sciences recently showcased its PhAROS drug discovery platform at the ALCOR Drug Discovery Platform Summit. The platform uses artificial intelligence (AI) and machine learning to identify and predict the efficacy of combinations of novel active ingredients from plants.
The company reports that to date, the platform has identified potential plant-inspired therapeutic mixtures for the treatment of neurological disorders, inflammation, anxiety, depression, heart disease, metabolic syndrome, chronic pain, and other conditions. These minimum essential mixtures were then validated in cell and now animal models in preparation for safety and efficacy testing in human clinical trials.
